Computational Approaches for Translational Oncology: Concepts and Patents

Abstract

Background: Cancer is a heterogeneous disease, which is based on an intricate network of processes at different spatiotemporal scales, from the genome to the tissue level. Hence the necessity for the biomedical and pharmaceutical research to work in a multiscale fashion. In this respect, a significant help derives from the collaboration with theoretical sciences. Indeed, mathematical models can provide insights into tumor-related processes and support clinical oncologists in the design of treatment regime, dosage, schedule and toxicity. Objective and Method: The main objective of this article is to review the recent computational-based patents which tackle some relevant aspects of tumor treatment. We first analyze a series of patents which concern the purposing or repurposing of anti-tumor compounds. These approaches rely on pharmacokinetics and pharmacodynamics modules, that incorporate data obtained in the different phases of clinical trials. Similar methods are also at the basis of other patents included in this paper, which deal with treatment optimization, in terms of maximizing therapy efficacy while minimizing side effects on the host. A group of patents predicting drug response and tumor evolution by the use of kinetics graphs are commented as well. We finally focus on patents that implement informatics tools to map and screen biological, medical, and pharmaceutical knowledge. Results and Conclusions: Despite promising aspects (and an increasing amount of the relative literature), we found few computational-based patents: there is still a significant effort to do for allowing modelling approaches to become an integral component of the pharmaceutical research.

PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective

“…It analyzed complex data sets such as genomics, proteomics, transcriptomics, metabolomics, glycomics, lipidomics from various experimental data sets to use computational tools. Cancer system biology deal with specific data sets such as patients samples, high-throughput patient’s genome, cancer cell lines, xenograft models, next-generation sequencing, siRNA based screenings, somatic mutations and genome instability [169].…”

Pharmaceutical patent landscaping: A novel approach to understand patents from the drug discovery perspective

“…Recently, there has been an increase in the attention given to patent documents as an aid to monitor advancements in drug discovery. This is seen in the field of oncology drug discovery, where patenting activity 1/18 is intense, and patents offer a window into the latest techniques in translational cancer therapies [3][4][5]. To support these efforts, oncology-specific patent datasets have been catalogued by established patent offices such as the USPTO Cancer Moonshot Patent Data (https://www.uspto.gov/ip-policy/economic-research/research-datasets/cancer-moonshot-patent-data).…”